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Several studies have demonstrated the important role of non-coding RNAs as regulators of
posttranscriptional processes, including stem cells self-renewal and neural differentiation.
Human embryonic stem cells (hESCs) and induced pluripotent stem cells (ihPSCs) show
enormous potential in regenerativemedicine due to their capacity to differentiate to virtually
any type of cells of human body. Deciphering the role of non-coding RNAs in pluripotency,
self-renewal and neural differentiation will reveal new molecular mechanisms involved in
induction and maintenances of pluripotent state as well as triggering these cells toward
clinically relevant cells for transplantation. In this brief review we will summarize recently
published studies which reveal the role of non-coding RNAs in pluripotency and neural
differentiation of hESCs and ihPSC.
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INTRODUCTION
Personalized medicine is expected to beneﬁt from the combina-
tion of genomic information with the high throughput studies
including transcriptomic, proteomic and metabolomic proﬁl-
ing. Measuring gene expression in individual cells is crucial for
understanding the gene regulatory network. In order to deci-
pher the genetic regulatory network in cells signiﬁcant efforts
have been made over the years to develop technology plat-
forms for transcriptome characterization such as DNA microarray
hybridization, serial analysis of gene expression (SAGE;Velculescu
et al., 1995) or next-generation RNA sequencing often called
RNA-seq (Mortazavi et al., 2008).
The latest techniques which involve bioinformatic expertise
made a revolution in transcriptome analysis enabling not only
the identiﬁcation of cDNA and gene isoforms but discovery of
long non-coding RNA (large intergenic non-coding RNA, lin-
cRNA; >200 nucleotides in length) and short non-coding RNA
(sncRNA,<200 nucleotides in length). Non-coding RNAs include
transfer RNA (tRNA), ribosomal RNA (rRNA), small nuclear and
small nucleolar RNA, microRNA (miRNA), and small interfer-
ing RNA (siRNA), which do not encode any proteins. Several
of these non-coding RNA species, like miRNA or SiRNAs, are
of particular interest to transcriptomic and particularly in stem
cell research due to their role in post-transcriptional regulation
of numerous biological processes (Morozova and Marra, 2008;
Roukos, 2010). During the last several years many studies were
published in order to determine the function of these non-
coding transcripts including novel miRNA (Hafner et al., 2008)
that exhibit different cell-type and tissue speciﬁcity (Guttman
and Rinn, 2012). Although the functions of the majority of
newly discovered non-coding RNAs are still unknown, some
were found to play important roles in the regulation of stem
cells. Recent studies concentrate on miRNAs (Wilson et al., 2009;
Kim et al., 2011; Lipchina et al., 2011). In the context of stem
cell biology, of particular interest is the role of these RNAs
in expression of renewal genes in human embryonic stem cells
(hESCs) or in regulation of induced pluripotency (Li et al.,
2011). In this review, we focus on recent discoveries of non-
coding RNA roles in human pluripotent stem cell biology and
differentiation.
HUMAN EMBRYONIC STEM CELLS AND INDUCED
PLURIPOTENT STEM CELLS
Human pluripotent stem cells encompassing hESCs and induced
pluripotent stem cells (ihPSCs) show great potential for regen-
erative biology providing the unique human in vitro plat-
forms for studying diseases, basic cell biology and develop
ment.
Human embryonic stem cells can be derived from inner mass
from human blastocyst maintaining unique capacity for unlim-
ited self-renewal through long-termmaintenance using laboratory
culture conditions (Thomson et al., 1998). Since the generation of
the ﬁrst hESCs line in 1998 (Thomson et al., 1998), research in this
area has progressed at a rapid pace, developing efﬁcient proto-
cols globally for differentiation of these cells to clinically relevant
cell types (Erceg et al., 2008, 2009, 2010, 2012). hESCs represent
a useful model for studying early human embryology and cell
differentiation and have limited capacity for disease modeling in
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human cells (Biancotti et al., 2010). hESCs bear the advantage
over any other stem cells in that they are pluripotent, provid-
ing an unlimited starting cell source for differentiation to any
type of tissue of the human body. The perspective of clinical
use of these cells and their derivates is huge. The hESCs-based
therapy is increasingly recognized as a promising strategy for
degenerative disorders entering already in clinic to treat spinal cord
injury or recently published encouraging results in human clinical
trial investigating their use in age-related macular degeneration
(Schwartz et al., 2012). The main disadvantage of use of hESCs in
regenerative medicine is the fact that derivation of hESCs requires
the destruction of human embryos which generates the ethical
concerns.
Besides the abundance and efﬁcient differentiation without
traces of pluripotency, the main requisite for personalized regen-
erative medicine is to derive disease cells that genetically match
the patient. Although the technique of somatic cell nuclear trans-
fer (SCNT) and successive derivation of hESCs (Tachibana et al.,
2013) could be a promising approach in the future to create patient
speciﬁc cells,major technical and ethical obstacles relatedwith this
technique are present.
The discovery of human ihPSCs originally generated by ectopic
expression of four transcription factorsOct4, Sox2, Klf4, and cMyc
(Takahashi et al., 2007) in human ﬁbroblast cells presents a novel
tool toobtaindisease cells. ThisNobel Prizewinner technologywas
substantially improved by introducing non-integrative transgene
expression (Jin et al., 2012) and targeting different somatic tis-
sues. Patient-speciﬁc ihPSCs derived from somatic cells are devoid
of immnunological and ethical concerns, allow the generation of
disease-speciﬁc stem cells providing a platform to study molecular
mechanisms of genetic diseases. The ihPSCs show morphological,
transcriptional, epigenetic, and phenotypic similarity to hESCs
and can differentiate toward any cell of human body. Until now a
number of studies has shown that ihPSCs can be successively gen-
erated from patients carrying different diseases and be a faithful
platform for disease modeling in vitro (Gunaseeli et al., 2010; Har-
gus et al., 2010; Jin et al., 2011, 2012; Pedrosa et al., 2011; Kumano
et al., 2012; Oh et al., 2012; Sun et al., 2012; Cocks et al., 2013;
Gross et al., 2013; Tubsuwan et al., 2013).
Pluripotent stem cells possess two major characteristics: self-
renewal and differentiation into other cell types. The investi-
gators put the major effort in development of new protocols
and moving these cells to clinics but it is crucial to under-
stand these two main characteristics in order to enter deeply
in basic biology of these cells. For example it is still to be
elucidated reprogramming mechanisms in target cells and why
only small population of cells becomes fully reprogrammed. In
order to decipher molecular mechanisms of reprogramming the
role of RNA and related global gene expression changes is of
particular interest in order to increase reproducibility and efﬁ-
ciency of reprogramming processes. Reproducible generation of
speciﬁc cellular type without traces of ihPSCs is one of the
crucial issues in order to prevent teratoma generation in host.
Improvements of the differentiation protocols are required as a
basis for further cost-efﬁcient industrial processes of large-scale
for future application in clinics. To reach this also extensive
characterization of differentiated cell has to be performed and
subsequently compared with undifferentiated counterparts. Com-
parative transcriptome analyses using microarray also indicate
that hESCs and hiPSCs have similar, highly alike gene expres-
sion patterns. Gene expression pattern of ihPSCs is separate
from the originating somatic cells with possibility of retain-
ing some transcriptional differences or an epigenetic memory
of the starting cells (Plath and Lowry, 2011). Transcriptome
characterization would undoubtedly provide insights into the
genetic regulatory networks involved in maintaining pluripotency
and directing differentiation. In order to deﬁne molecularly the
various phases of the reprogramming process, as well as full
pluripotent stem cells state global gene expression and proteomic
patterns of clonal cell populations or enriched populations need
to be performed in different stages after inicial reprogramming
induction.
PLURIPOTENCY
Generally, a deﬁnition of pluripotency is related to ability of cell to
give rise three germ layers: endoderm, ectoderm, and mesoderm
and their derivates. This ability has only a small number of cells
such as hESCs and ihPSCs and their maintenance involves core
transcription factors: Oct4, Sox2, and Nanog (Boyer et al., 2005;
Kim et al., 2009). A spectrum of different miRNA was detected
in embryonic stem cell as pluripotency-speciﬁc markers which
expression was downregulated during the induction of differen-
tiation (Table 1; Wilson et al., 2009; Lee et al., 2010). A family
of miRNA that includes AAGUGC seed sequence is of particular
interest in pluripotent stem cells for its high expression in hESCs
and ihPSC. Themost abundantmiRNA transcript in hESCs ismir-
302 which encodes for miR-302a/b/c/d and mir-367 (Suh et al.,
2004) and is under the control of Oct4, Sox2, and Nanog. This
miRNA is involved in maintenance of pluripotency, self-renewal,
regulationof cell cycle, and fate speciﬁcationduringdifferentiation
of hESCs (Suh et al., 2004; Landgraf et al., 2007; Bar et al., 2008;
Lipchina et al., 2011) probably inhibiting neural differentiation
by modulation of BMP signaling targeting its inhibitors: TOB2,
DAZAP2, and SLAIN1 (Lipchina et al., 2011). Rosa and Brivan-
lou (2011) have shown that Oct4 and miR-302 inhibit NR2F2,
which in turn inhibits Oct4. The expression of gene NR2F2 is
increased during differentiation when the expression of OCT4
gene and miR-302 declines (Rosa and Brivanlou, 2011). This study
showed important biological function of mir-302 and NR2F2 in
human early development and cell fate determination. It seems
that other miRNAs such as miR-145 has the opposite role in main-
tenance of pluripotency (Xu et al., 2009). The expression of this
miRNA is low in undifferentiated hESCs but its increased expres-
sion is related to inhibition of hESCs self-renewal and induction
of lineage-restricted differentiation (Xu et al., 2009).
Elucidation of the precise molecular and cellular mechanisms
which convert human ﬁbroblasts or other somatic cells to ihP-
SCs was the main challenge among the investigators during the
last years. Reprogramming somatic cells into pluripotent cellu-
lar identity requires tightly regulated and coordinated changes
in expression of many genes. Understanding the genetic net-
work involved in cellular reprogramming is crucial to elucidate
pluripotency in order to increase the reprogramming efﬁciency
and cell renewal. These mechanisms will reveal why only small
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Table 1 | Different roles of non-coding RNA in pluripotency and neural differentiation.
Type of cells Processes involved Non-coding RNA Reference
hESC Pluripotency, self-renewal, cell cycle
and fate speciﬁcation
miR-302 Suh et al. (2004), Bar et al.
(2008), Lipchina et al. (2011)
hESC Inhibition of pluripotency miR-145 Xu et al. (2009)
iPSC Pluripotency miR-17, miR-106b, and miR-106a Li et al. (2011)
Fibroblasts to iPSC Reprogramming miR-302, miR-372 Anokye-Danso et al. (2011, 2012),
Subramanyam et al. (2011)
Fibroblasts to iPSC Reprogramming Combination of miR-302, miR-200c,
and miR-369
Miyoshi et al. (2011)
iPSC Reprogramming LincRNAs Loewer et al. (2010)
hESC Neural differentiation LincRNAs Ng et al. (2012)
iPS-derived neural progenitors Neural differentiation LincRNAs Lin et al. (2011)
hESC Differentiation to neuroectoderm miR-200, miR-96 Du et al. (2013)
hESC-derived neural stem cells Suppression of selfrenewal, neural
differentiation
miR-124, miR-125b and miR-9/9 Roese-Koerner et al. (2013)
hESC Neural differentiation miR7 Liu et al. (2012)
hESC Neural differentiation miR125 Boissart et al. (2012)
hESC, human embryonic stem cells; iPSC, induced pluripotent stem cells.
population of somatic cells undergo full reprogramming. Dif-
ferent gene expression patterns and post-transcriptional events,
including mRNA decay, between pluripotent and differentiated
cells could reveal the reprogramming mechanisms of the ﬁbrob-
lasts into ihPSCs. The study of Buganim et al. (2012) showed that
reprogramming involves stochastic gene expression in early phase
followed by a late hierarchical phase with activation of SOX2 gene,
which then triggers a stepwise gene activation that allows the
cells to enter the pluripotent state. SOX2 represents a group of
pluripotency initiating factors (PIFs) indispensable for endoge-
nous activation of OCT4, SOX2, and NANOG (Boyer et al., 2005)
which further maintain the ihPSCs state. Some of these genes
maintain pluripotency by blocking the gene machinery involved
in differentiation.
In the study of Li et al. (2011) was observed that three miRNA
clusters: miR-17, miR-106b, and miR-106a were signiﬁcantly
upregulated that interfere with iRNA machinery directly con-
nectedwith important reprogramming pathways: TGF-β signaling
and cell cycle. These results suggest that transcription factors that
modulate miRNA decay could have crucial role in reprogramming
differentiated cells or inmaintainingpluripotency, but future stud-
ies have to be performed to conﬁrm whether these factors can be
efﬁcient target to induce or maintain the pluripotency or trigger
the differentiation.
Several miRNA, especially miR-302 and miR-372 have been
directly involved in enhancing of HFF reprogramming (Sub-
ramanyam et al., 2011) revealing the possibility to directly tar-
get these miRNAs to reprogram the HFF without Yamanaka
factors. The recent study of Morrisey and colleague (Anokye-
Danso et al., 2011, 2012), conﬁrmed that reprogramming can
be achieved by using miRNAs without protein-coding fac-
tors. Another study conﬁrmed that fully pluripotent stem
cells can be obtained by introducing other miRNA such as
combination of miR-302, miR-200c, and miR-369 (Miyoshi
et al., 2011). Different studies speculated about the mechanisms
and signaling pathways by which these miRNAs exert their
reprogramming function such as regulation of different genes
involved in cell cycle, epithelial-mesenchymal transition, epi-
genetic regulation and vesicular transport (Subramanyam et al.,
2011).
On the other hand, the abundance of lincRNAs in mammalian
transcriptome reveals their role as key regulators of biological pro-
cesses. These RNA transcripts have little or no protein coding
potential but some studies point out their possible participation
in pluripotency, differentiation and self-renewal (Guttman et al.,
2009,2011; SheikMohamed et al., 2010; Guttman andRinn,2012).
Several studies have recently discovered a novel class of lincRNAs
possible involved in reprogramming processes, pluripotency and
lineage commitment (Boyer et al., 2006; Lee et al., 2006; Loewer
et al., 2010).
Some of these lincRNAs act directly as regulators of reprogram-
ming (RoR) called lincRNA-RoR (Loewer et al., 2010). Overex-
pression of these RNAs signiﬁcantly enhances the reprogramming
efﬁciency and their downregulation decreases the generation of
ihPSC colonies possibly by mechanism of negative regulation of
p53 (Zhang et al., 2013).
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These studies indicate that non-coding RNAs, especially miR-
NAs have the potential to be used as small-molecule therapeutics
to promote more efﬁcient reprogramming or to induce the
pluripotent stem cells toward other cell lineages.
DIFFERENTIATION
In the context of regenerative medicine it is crucial to develop
protocols for efﬁcient and reproducible differentiation of pluripo-
tent stem cells toward homogeneous population of desired cells
without traces of pluripotency. Since the generation of the ﬁrst
hESCs line (Thomson et al., 1998) and derivation of ihPSC (Taka-
hashi et al., 2007), research in this area has progressed at a rapid
pace, developing efﬁcient protocols globally for differentiation
of these cells to clinically relevant cell types. As already men-
tioned, hESCs and ihPSCs bear the advantage over any other
stem cells in that they are pluripotent, providing an unlim-
ited starting cell source for differentiation to any type of tissue
of the human body. Understanding the regulatory mechanisms
which orchestrate the hESCs and ihPSCs during differentiation
is of enormous importance because coordinated changes in gene
expression during the differentiation of hESC and ihPSC are cru-
cial for lineage speciﬁcation. Beside the gene expression changes
in coding RNA it is a clear to investigate whether non-coding
RNA play important role in early differentiation of pluripotent
stem cells. Although recent studies have shown that ihPSCs lines
exert better differentiation capacity when compared with hESCs
(Hu et al., 2010) direct comparison of differentiated cells versus
undifferentiated counterparts is crucial in order to ﬁnd signaling
mechanisms involved indifferentiation. In the recent studyGifford
et al. (2013) performed comprehensive transcriptional proﬁl-
ing of cell populations generated by directed differentiation of
hESCs.
To reveal whether lincRNAs play important role in hESCs
and neural differentiation Stanton and colleague (Ng et al., 2012),
employed a highly efﬁcient protocol for neural differentiation of
hESCs based on stromal-derived induction activity (SDIA) using
co-culture of hESCswith PA6mouse stromal cells. This procedure,
used by many groups, was designed to generate homogeneous
population of neural progenitor cells and further dopaminergic
neurons (Kawasaki et al., 2000, 2002; Zeng et al., 2004). About 36
lincRNAs were identiﬁed which were associated with pluripotency
making the complex with SOX2, and SUZ12, well known genes
involved in pluripotency. Association of newly discovered lincR-
NAs with MIR-125B and LET7A reveal important role of these
lincRNA in neurogenesis and neural differentiation. These results
demonstrate that lincRNAs represents indispensable components
in regulation of biological processes such as neural differentiation
and pluripotency.
In order to clarify the contribution of lincRNA in developmen-
tal and neurological disorders, Lin et al. (2011) were performed
Genome-wide analysis using next-generation sequencing (RNA-
Seq) of neural progenitors derived from ihPSCs. They found
that early differentiated cells underwent dramatic quantitative
changes in gene expression especially lincRNAs. The authors
associated many lincRNAs with HOX gene (HOXA and HOXB),
genes involved in early patterning of anterior posterior axis dur-
ing the neural development. These results coincided with results
obtained with neural progenitors derived from hESCs as an addi-
tional prove that these two sources of pluripotent stem cells has
similar neuronal differentiation potential (Wu et al., 2010). The
author’s general aim in this article is to associate the obtained
results with some neuropsychiatric disorders in order to establish
faithful lincRNA markers. The RNA-Seq ﬁndings highlighted
possible non-coding RNA variants as feasible candidates which
mutations are involved in many neuropsychiatric disorders mostly
schizophrenia, bipolar disorders and autism spectrum disorders.
These transcription factors and chromatin modiﬁers candidate
are: POU3F2, MYTIL, RFX4, ZNF804A, SMARCA2, and NPAS3.
These changes in the transcriptome proﬁles and the role of
lincRNA during early human neural differentiation using pluripo-
tent stem cells reveals important use of ihPSC technology in
studying humandisease as a unique human assay of humanneuro-
genesis. Integration the novel transcripts inmore global systems of
analysis is must in order to elucidate their abnormally regulation
in a subgroup of patients.
Comparing the miRNA proﬁles of neuroectodermal cells to
epidermal cells both derived from hESC, Zhang and colleague
(Du et al., 2013) identiﬁed the downreglation of two miRNA fam-
ilies in neuroectodermal differentiated cells, miR-200 and miR-96.
Investigating the function of these miRNA it was discovered that
miR-200 regulates the level of zinc-ﬁnger E-box-binding home-
obox (ZEB), transcription factor family involved in inhibition of
expression of BMP and its downstream genes, thus promoting
neural differentiation (Postigo et al., 2003), while miR-96 regulates
PAX6 (paired box 6), well known transcription factor character-
istic for neuroectoderm. The authors also ﬁnd that upregulation
of these miRNA suppresses differentiation of hESCs toward neu-
ral lineage (Du et al., 2013). Recent article examined the role of
the neural-associated miR-124, miR-125b, and miR-9/9 in human
neural stem cells derived from human pluripotent stem cells
(Roese-Koerner et al., 2013) and showed that overexpression of
these miRNA suppress self-renewal and induce further differenti-
ation into neurons. Providing additional evidence of involvement
of other miRNA such as miR7 (Liu et al., 2012) and miR125 (Bois-
sart et al., 2012) in neural differentiation of hESCs, these studies
showed that neural stem cells derived from pluripotent stem cells
could be a faithful model for investigation of role of miRNA in
modulating of stemness and neuronal differentiation capacity of
these cells.
CONCLUSION
Studying of non-coding RNA in modeling exhaustive networks
of gene interactions as an ultimate application of systems biol-
ogy in systems biomedicine, could substantially contribute to
understanding and modulation of developmental and differen-
tiation processes in humans. Although the expression of newly
correlated non-coding RNA is strongly associated to pluripo-
tency and neural differentiation their possible role in differ-
ent neurodegenerative disorders is still to be elucidated. These
studies undoubtedly contribute to better understanding of the
biological processes during pluripotency and neural differen-
tiation and reveal the important interplay between multiple
pluripotency transcription factors and non-coding RNAs espe-
cially miRNAs. However, the understanding of the impact of
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miRNA-based regulation in human neural development is still
at its dawn. The future studies will conﬁrm the potential of con-
trolling differentiation and pluripotency of human pluripotent
stem cells by modulating the expression of selected non-coding
RNAs and integrate them into models that reveal the global
behavior of the biological process in biomedicine and neu-
ral diseases in order to ultimately improve patients’ quality of
life.
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